CIK 0001807120
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
Design Therapeutics, Inc.
Sign in to watch- Ticker
- DSGN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 823929248
- Phone
- +1 858-293-4900
- Business address
- 6005 HIDDEN VALLEY ROAD, SUITE 110, CARLSBAD, CA, 92011
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy Director bought 40,000 shares at $15.45 ($618,000)
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy Chief Operating Officer bought 3,050 shares at $20.00 ($61,000)
- 4 Conversion 10% owner acquired 4,720,830 shares (conversion)
- 4 Open-market buy 10% owner bought 250,000 shares at $20.00 ($5,000,000)
- 4 Open-market buy Director bought 10,000 shares at $20.00 ($200,000)
- 4 Open-market buy Director bought 250,000 shares at $20.00 ($5,000,000)
- 4 Open-market buy Director bought 5,000 shares at $20.00 ($100,000)
- 4 Open-market buy Executive Chairperson bought 25,000 shares at $20.00 ($500,000)
- 4 Open-market buy Vice President, Finance bought 17,500 shares at $20.00 ($350,000)
- 4 Open-market buy Director bought 700,000 shares at $20.00 ($14,000,000)
- 4 Open-market buy Former 10% Owner bought 750,000 shares at $20.00 ($15,000,000)
- 3/A Insider 3/A
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 5 of 6 · 117 filings